80 likes | 81 Views
People with low immunity are more prone to Cryptococcosis infections. According to the Centers for Disease Control and Prevention (CDC), cryptococcosis infections are common in people with a weak immunity (especially those having advanced HIV/AIDS) and in people taking corticosteroids or other medications that weaken immunity. People with HIV & AIDS are very susceptible to all types of infections including cryptococcosis infections. According to the World Health Organisation (WHO), HIV is a major global public health concern and takes claimed 40.1 million (33.6u201348.6 million) lives.
E N D
Cryptococcosis MarketMarket size, Industry outlook, Market Forecast, Demand Analysis, Market Share, Market Report 2022-2027 Contact: Venkat Reddy sales@industryarc.com (+1) 970-236-3677
DownloadPDF Brochure • Cryptococcosis Market Size is estimated to reach $7.8 billion by 2027 and is poised to grow at a CAGR of 7.1% over the forecast period of 2022-2027. Cryptococcosis is an infection commonly associated with immunosuppressive individuals and is caused by Cryptococcus fungus. The initial symptoms are frequently chronic and develop over more than a few weeks. • Meningitis (brain infection) and pulmonary infection or lung infection are the two main physical symptoms of the illness. Numerous factors, including an increase in AIDS prevalence and prolonged use of immunosuppressive medications, have contributed to an increase in the incidence of cryptococcosis over time. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure Key Takeaways Geographically, North America held a dominant market share in the year 2021. Better diagnostic techniques in this region and various treatments available to cure such infections boost the growth of the Cryptococcosis Market size. The Cryptococcosis Market is predicted to increase due to the increase in consumption of immunosuppressant drugs and the growing prevalence of autoimmune diseases, fuelling the growth of the Cryptococcosis Market. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure Cryptococcosis Market Segment Analysis - by Treatment The Cryptococcosis Market based on the treatment can be further segmented into Amphotericin B (Amphocin and Fungizone), Flucytosine (Ancobon), Fluconazole Drugs (Diflucan), Voriconazole and Surgery Treatment. The Amphotericin B (Amphocin and Fungizone) segment held a dominant market share in the year 2021. As Amphotericin B is useful in the first treatment for widespread cryptococcosis infection. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure • Cryptococcosis Market Industry Outlook • Bristol-Myers Squibb Company • Janssen Biotech Inc. (Johnson & Johnson) • Abbott Laboratories • Novartis AG • Pfizer Inc. Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure Cryptococcosis Market - Forecast(2022 - 2027) LearnMoreAbouttheReport @ https://www.industryarc.com/Report/17395/cryptococcosis-market.html Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure • You Can Customize the Report as Per YourNeed. We have included Some CustomizationOptions: • CompanyProfile • AnalystBriefing • DataTables • KeyContacts • FreeCustomization • Purchase Full Report @https://www.industryarc.com/purchasereport.php?id=17395 Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com
DownloadPDF Brochure For More DetailsContact VenkatReddy Contact: (+1)970-236-3677 Email:sales@industryarc.com Connect with us on LinkedIn @ http://www.linkedin.com/company/industryarc Contact: (+1)970-236-3677 InquiryBefore Buying Email:sales@industryarc.com